Amgen Bioprocessing Center
The Amgen Bioprocessing Center is one of the most important teaching and research laboratories at Keck Graduate Institute. Founded in December 2004 thanks to a $2 million gift from The Amgen Foundation, the Center serves as the basis for the bioprocessing focus track offered as part of KGI's Master of Bioscience (MBS) degree program.
The Amgen Bioprocessing Center is a state-of-the-art facility where MBS students learn the skills necessary to become leaders in bioprocessing. Bioprocessing refers to the manufacture of valuable products through the culture of living microorganisms. Products from bioprocessing include many life-saving biopharmaceuticals and antibiotics, renewable biofuels such as ethanol and biodiesel, and fermented beverages, such as wine and beer. Today, over one-third of all medical products in active development are biopharmaceuticals. Life-changing therapeutics such as human insulin and human growth hormone (for children with growth hormone deficiency) have improved the quality of life for thousands of people suffering from diabetes, cancer, arthritis, cardiovascular disease and infectious diseases.
The Amgen Bioprocessing Center is run by Dr. Parviz Shamlou, KGI's George B. and Joy Rathmann Professor.
November 13, 2013
KGI Collaborates with Biocon to offer the 'Biocon KGI Certificate in Biosciences'
May 22, 2013
Dr. Matt Croughan to Become Chief Technology Officer at Sapphire Energy
March 16, 2011
Prof. Croughan to Give Keynote at AAICHE Annual Symposium
February 24, 2011
Bioprocessing Adjuncts Share Expertise at Forefront of Industry